Trial intelligence / Profile preview

Occurrence of acid-related symptoms after withdrawal of proton pump inhibitors in healthy volunteers

2004-004239-78Phase 4Active

Sponsor
Institute of Medicine, University of Gothenburg
Start
Apr 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of pantoprazole and esomeprazole in gastroesophageal reflux disease (GERD) and Acid Peptic Disease (APD), sponsored by Institute of Medicine, University of Gothenburg. Started Apr 2005; status: active.

02

Drugs

pantoprazoleesomeprazole
03

Conditions

gastroesophageal reflux disease (GERD)Acid Peptic Disease (APD)

Beyond the preview

Go deeper on 2004-004239-78.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004239-78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call